At a glance
ClinicalIndex Comparison Record- ✓Suspected stroke identified by the Los Angeles Prehospital Stroke Screen
- ✓Age 40–95 years, inclusive
- ✓Last known well time within 2 hours of treatment initiation
- ✓Neurologic deficit present for at least 15 minutes
- ✕Coma at presentation
- ✕Rapidly improving neurologic deficit
- ✕Systolic Blood Pressure <90 or >220 mmHg
- ✕Severe renal dysfunction (on dialysis or serum creatinine >3.0 mg/dL)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Field Administration of Stroke Therapy-Magnesium Trial: A Randomized, Double-Blind, Placebo Controlled Trial of Neuroprotective Magnesium Sulfate Therapy for Acute Stroke Initiated Within 2 Hours of Onset by Paramedics in the Field
In Brief
A Phase 3 clinical trial evaluating Magnesium Sulfate and Normal Saline for Cerebrovascular Accident. Completed, enrolled 1,700 participants across 1 site.
Detailed Summary
The goal of this study is to evaluate the effectiveness and safety of field-initiated magnesium sulfate in improving the long-term functional outcome of patients with acute stroke.
Study Details
Timeline
Interventions
Paramedics initiate a loading dose of 4 grams magnesium sulfate IV over 15 minutes, followed after hospital arrival by a maintenance infusion of 16 grams magnesium sulfate IV over 24 hours.
Paramedics initiate a loading dose of placebo normal saline IV over 15 minutes, followed after hospital arrival by a maintenance infusion of placebo normal saline IV over 24 hours.